Seagen is a global biotechnology company dedicated to revolutionising cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.
Seagen U.K. Ltd.
The Charter Building
Uxbridge UB8 1JG
Medical Information and Safety
To report an adverse event or request additional information about our medicines, please contact our Medical Information team via email MedInfoEU@seagen.com or alternatively call (+44) 330 818 0490. Our Medical Information team is available from Monday to Friday from 9am to 5pm GMT.
Companies House Registry 06321958 - VAT GB355368868
Job Code UK/COR/2023/0005